logo-loader
viewPolynovo Ltd

Polynovo follows swift re-rating with a capital raising

The halt will remain in place until Tuesday 25th September 2017.

1506037874_rsz_shutterstock_276800108.jpg
The company's shares are in pre-open

Polynovo Ltd's (ASX:PNV) shares last traded at $0.285, or around 60% higher than a month ago, with the company receiving a positive re-rating following its first U.S. sales of NovoSorb BTM™

NovoSorb is a tissue scaffold that facilitates the regeneration of the dermis when it has been lost or damaged through trauma, burns, surgery or wounding.

Polynovo is now heading to market with a capital raising, and the ASX has granted a trading halt to prepare.

The halt will remain in place until the opening of trade on Tuesday 25th September 2017, or earlier if an announcement is made to the market.

Quick facts: Polynovo Ltd

Price: 1.915 AUD

ASX:PNV
Market: ASX
Market Cap: $1.27 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Southern Gold active on the ground in South Korea with multiple rigs and...

Southern Gold Limited's (ASX:SAU) managing director Simon Mitchell tells Proactive London's Andrew Scott they're looking to become recognised as the go-to name for exploration in South Korea.  ''We're now 100% focused on South Korea and I think that's been well received by the market to...

4 hours, 12 minutes ago

2 min read